Heart failure
Revised ACC/AHA HF guidelines address aldosterone, device use, quality of life
Jun 14, 2013 17:30 EDT
The just-released 2013 ACC/AHA HF guidelines present a strong evidence-based approach that covers the spectrum from screening for the disease, through treatments, to discussing end-of-life care.

Washington, DC - The just-released 2013 American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for heart failure present a strong evidence-based approach that covers the spectrum from screening for the disease, through treatments, to discussing end-of-life care [1].

This is the third full rewrite of the previous guidelines that were issued in 2000, and it reflects the advance in medicine and the growing body of evidence that has become available to guide treatment decisions. The guidelines will be published in the August 27, 2013 issue of the Journal of the American College of Cardiology.
Read full article »

Hypertension
Spironolactone provides benefit in resistant hypertension, small study shows
Jun 17, 2013 09:45 EDT

Arrhythmia/EP
Severe sleep apnea may almost double risk of sudden cardiac death
Jun 12, 2013 17:00 EDT

Hypertension
Higher LV mass after preeclampsia predicts later hypertension
Jun 7, 2013 17:00 EDT

Lipid/Metabolic
Rosiglitazone restrictions should be eased, says FDA advisory panel
Jun 6, 2013 21:45 EDT

Lipid/Metabolic
FDA says again: Rosiglitazone does not up CV risk 
Jun 6, 2013 12:15 EDT

Heart failure
Chinese herbal medicine shows promise in HF in early trial
Jun 4, 2013 15:30 EDT

Editorial programs
Debate and dialogue between top cardiovascular specialists, produced by
theheart.org's editorial team
View all »
Life and times of leading cardiologists. Guest: Richard Schatz
Life and times of leading cardiologists. Guest: Richard Schatz
Jun 3, 2013 09:45 EDT
Healthcare reform and cardiology: An even-keeled update
Healthcare reform and cardiology: An even-keeled update
May 2, 2013 08:45 EDT
Breaking embargo: PREVAIL and how we publish data from clinical trials
Breaking embargo: PREVAIL and how we publish data from clinical trials
Apr 12, 2013 16:33 EDT
View all »Collections
heartwire collections groups our most compelling cardiology news coverage and editorial content by popular themes. Find everything on a single topic, in one place, with one click.
The Myxo ring mix-up
In 2008, a heartwire investigation reported on a mitral annuloplasty ring, invented by...
MRIs and implantable device safety
Magnetic resonance imaging tests are increasingly being used for diagnosing forms of...
Rosiglitazone wrangling
A controversial 2007 meta-analysis questioning the cardiovascular safety of...
Drugs, money, and glory: Is cancer beating cardiovascular disease?
Heart disease still tops the charts as the number-one killer in most developed...
Omega-3 fatty acids and cardiovascular disease
Randomized clinical trials dating back to the GISSI Prevenzione study have cemented a...